Pharma Co. PhaseBio Can Exit Ch. 11 With Wind-Down Plan

By Clara Geoghegan · June 26, 2024, 3:59 PM EDT

A Delaware bankruptcy judge on Wednesday gave her blessing for pharmaceutical developer PhaseBio Pharmaceuticals Inc. to liquidate its assets and wind down after settlement agreements with creditors and a business partner...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

PhaseBio Pharmaceuticals, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

October 23, 2022

Recent Articles By Clara

June 28, 2024
Ex-NS8 Exec Was 'Willing Participant' In Fraud, Trustee Says
June 27, 2024
Sandy Hook Families Can't Seize Funds From Alex Jones' Co.
June 26, 2024
Tech Co. GigaMonster Seeks Vote For Ch. 11 Wind-Down Plan
June 25, 2024
Meet The Lawyers Powering EV Startup Fisker Group's Ch. 11
June 24, 2024
LifeWallet Calls Cano Health's Ch. 11 Plan Unconfirmable
June 24, 2024
Biotech Co. Hits Ch. 11 With Plans For Sale And 'Reboot'
June 21, 2024
Robertshaw Cleared For Ch. 11 Sale As Invesco Claims Loom
June 20, 2024
Spinal Implant Maker Can Liquidate Under Ch. 11 Plan
June 18, 2024
Biotech Co. NanoString Gets OK On Ch. 11 Wind Down Plan
June 17, 2024
Deutsche Bank Sues Over Stalled Lehman Claim Deal